Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-006477

Options or other derivatives

  • President & CEO acquired 47,495 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-14 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +47,495 47,495 D
Loading xslF345X03/form4.xml…